Solving the Solvable Problem of Diversity in Clinical Trials: 2023 Best of Breast Conference

 

Dr Jennifer Klemp, PhD, MPH, MA from University of Kansas Cancer Center comments on the problem of lack of diversity in cancer clinical trials: A need for a comprehensive approach to increase access, community outreach, and screening in minority populations.

 
 

Related Resources

 
Previous
Previous

Lack of Diversity in Cancer Clinical Trials: 2023 Best of Breast Conference

Next
Next

2022 Diversity in Cancer Care Webinars | Fireside Chat